Alopecia treatment, in simple terms, is a medical procedure used to stop hair loss. Hair loss and Alopecia can both be due to genetic factors as well as infections such as Herpes and HPV. Most people usually start losing hair at around the age of thirty or forty. It is a common genetic disease.
Hair loss occurs when hair follicles on the scalp fail to produce hairs normally, causing the scalp to become bald. There are many Alopecia treatment options available to stop the loss of hairs. There are a number of reasons for losing hair; stress, hormonal imbalances, diseases, nutritional deficiencies, malnutrition, and stress are just a few. There are also drugs that are prescribed for the treatment of alopecia. The most popular drugs for hair loss are topical minoxidil (Rogaine) and Finasteride (Propecia).
In July 2021, a biotechnology company, Kintor Pharmaceuticals received a clearance from the U.S. Food and Drug Administration (FDA) for GT20029, an investigational drug developed for the treatment of AGA (androgenetic alopecia). In the same timeframe, the Patient Recruiting Agency initiated the CTP-543 THRIVE Clinical Program to develop oral treatment for patients suffering from alopecia areata.
Other drugs that have been used as an Alopecia treatment market are drugs called anthralin, rogaine, and netilmyristam. Anthralin and Rogaine work by inhibiting the re-absorption of DHT on the scalp. DHT is the primary cause of male pattern baldness. Anthralin and rogaine work by inhibiting the production of testosterone thus eliminating the excess testosterone from the body, which can inhibit further hair loss.
Another common form of Alopecia treatment is the use of prescription medications. These medications are commonly used to treat persistent hair loss. Commonly prescribed medications are minoxidil (Rogaine) and hydrocortisone. Minoxidil works by suppressing the effect of testosterone, thereby stopping the increase of DHT in the scalp. Hydrocortisone is commonly used to reduce inflammation caused by shaving or trimming.
In the light of increased occurrence of alopecia conditions such as alopecia totalis, androgenic alopecia, and alopecia areata, the alopecia treatment market is poised to create tremendous business opportunities for its participants. Additionally, other factors shaping the future of the alopecia treatment market include the growing geriatric population, rising incidence of hair loss, and the technical improvements in alopecia therapy. Contrarily, the growing popularity of hair transplants and wigs can create a hindrance in the expansion of the alopecia treatment market.
In the territorial breakdown, the alopecia treatment market in the North American region is anticipated to expand at a scalable rate owing to the high number of alopecia treatments in parallel to the robust healthcare infrastructure. Also, the Asia Pacific region is posing a huge growth potential for the alopecia treatment market on the heels of advancements in medical facilities and increased healthcare expenditure.
